English
Home > Products > CAS:223673-61-8

China CAS:223673-61-8 Manufacturer

We are also focusing on improving the stuff management and QC system so that we could keep great advantage in the fiercely-competitive business for CAS:223673-61-8, Our organization has been devoting that "customer first" and committed to helping clients expand their small business, so that they become the Big Boss !
CAS:223673-61-8, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Related Products

Hot Products

  • Mifepristone

    Mifepristone

    Mifepristone has specifications of CP and IP. DMF and GMP approved.

    CAS:84371-65-3

  • Tibolone

    Tibolone

    Tibolone complies with EP specification. DMF is approved.

    CAS:5630-53-5

  • Abiraterone Acetate

    Abiraterone Acetate

    Abiraterone Acetate has CP,USP specifications. DMF, WC available.

    CAS:154229-18-2

  • Eplerenone

    Eplerenone

    Eplerenone has EP specifications. CEP available and FDA approved.

    CAS:107724-20-9

  • Oxcarbazepine

    Oxcarbazepine

    Oxcarbazepine has CP, EP and USP specifications. CEP and DMF available, GMP approved.

    CAS:28721-07-5

  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

  • Related Blog
  • Reviews

  • 2019 CPhI China Exhibition Shanghai

    June 2019
    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • 2024 CPhI Exhibition Shanghai

    In 2024, CPhI China will continue to be a unique opportunity for global pharmaceutical companies, manufacturers and suppliers. We will be waiting for you at the W1G20 booth on time to explore and interpret new trends in the pharmaceutical industry and interact with each other to further expand their business cooperation and various business opportunities. See you in Shanghai!

  • Gedian Humanwell successfully passed the EDQM audit

    The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

  • Join Us at Booth B9023 for Pharmtech & Ingredients 2025

    ​Pharmtech & ingredients 2025 will be held at International Exhibition Centre “Crocus Expo” from November 25-28, our booth number is B9023.

  • What Are Chemical Intermediates and How Are They Used in Pharmaceutical Manufacturing

    At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

  • Meet Us at CPHI Japan 2026 – Booth 2K32

    We will attend CPHI Japan 2026 at Tokyo Big Sight from April 21 to 23, with booth 2K32.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept